TLRY Research and Charts

TLRY - Tilray Inc (Healthcare: Drug Manufacturers - Specialty & Generic)

Projected Earnings Date: 2025-07-08 (Delayed quote data 2025-07-11)

Last 0.58	Change ⇓ -0.06 (0.00%)	Volume 34,889,700
	Open 0.63	High 0.63	Low 0.58

8EMA (Daily) 0.56	40EMA (Daily) 0.48	50EMA (Daily) 0.49	STO (Daily) 82.771	MACD Hist (Daily) 0.050
8EMA (Weekly) 0.481	40EMA (Weekly) 0.86	50EMA (Weekly) 0.99	STO (Weekly) 29.204	MACD Hist (Weekly) 0.083


Company Profile
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products through Manitoba Harvest and beer through SweetWater.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.